Day 1 – Monday 8th of June
Data and analysis from the Pfizer MATISSE trial
David Radley, Pfizer, USA
Abstract
Summary of the RSV vaccine findings on prematurity and how it informed impact studies
Prof. Shabir Madhi, University of Witwatersrand, South Africa
Abstract
Could statistical methods matter?
Prof. Stephen Evans, London School of Hygiene & Tropical Medicine, UK
Abstract
Immunogenicity and Safety assessment of GBS-NN/NN2 in Pregnant Women
Lidia Oostvogels, MinervaX, Denmark
Abstract
Planned safety assessment in Pfizer’s Phase-3 GBS trial, BEATRIX
David Radley, Pfizer, USA
Abstract
Safety and Immunogenicity of a two dose Ebola vaccine among pregnant women in Rwanda
Dr. Julien Nyombayire - Center for Family Health Research, Rwanda
Abstract
Mpox (MVA-BN) vaccination in pregnancy. Perspectives and challenges in data collection in remote resource-constrained settings (PregInPoxVac)
Paulina Morales Ruiz. Global Health Institute, University of Antwerp, Antwerp, Belgium
Solange Milolo. Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo
Abstract
Pregnancy outcomes following maternal vaccination with recombinant pertussis vaccines: evidence from three observational studies in Thailand
Dr. Souad Mansouri, BioNet Asia, Thailand
Abstract
Day 2 – Tuesday 9th of June
Contextualizing Prematurity
Dr. Jezid Miranda, University of Cartagena, Colombia
Abstract
Lessons Learned from Maternal Immunization
Prof. Janet Englund, Seattle Children's Hospital, USA
Abstract
Assessing the Safety of Maternal Immunization in Observational and Real-World Data: Lessons Learned from a Global Study
Dr. Benjamin Atkins, Murdoch Children’s Research Institute on behalf of Global Vaccine Data Network, Australia
Abstract
Is a different methodology needed for RCT’s and non RCT data sets?
Prof. Stephen Evans, London School of Hygiene & Tropical Medicine, UK
Abstract
How to tackle causality assessment of adverse events following immunization (AEFI) and maternal immunization (AEFMI)
Prof. Kathryn Edwards - Vanderbilt University, USA
Dr. Madhava Ram Balakrishnan – WHO, Switzerland
Abstract
Strengthening quality assurance in clinical research in resource-constrained settings: The ethical imperative to develop, implement, and evaluate ancillary care policies
Dr. Gwen Lemey, University of Antwerp
Abstract
